Related Experiment Video
Updated: Feb 18, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Thrombolytic therapy for deep venous thrombosis?
1Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. mhorne@nih.gov
Recombinant tissue plasminogen activator instillation improved a deep venous thrombosis patient. Further trials are needed to define thrombolytic therapy
Area of Science:
- Vascular Medicine
- Thrombosis Research
Background:
- Deep venous thrombosis (DVT) poses significant health risks.
- Current treatment guidelines for DVT vary in invasiveness.
Observation:
- A case study involving a bedridden patient with severe DVT.
- Intraclot instillation of recombinant tissue plasminogen activator (rt-PA) was administered.
Findings:
- The patient experienced remarkable improvement following rt-PA instillation.
- The efficacy of rt-PA for less symptomatic DVT remains undetermined.
Implications:
- Aggressive thrombolytic therapy may be beneficial in severe DVT cases.
- Further clinical trials are essential to establish clear recommendations for thrombolytic therapy in DVT.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction

